Mission
ASGCT'S MISSION IS TO ADVANCE KNOWLEDGE, AWARENESS, AND EDUCATION LEADING TO THE DISCOVERY AND CLINICAL APPLICATION OF GENETIC AND CELLULAR THERAPIES TO ALLEVIATE HUMAN DISEASE.
Public Charity
THE AMERICAN SOCIETY OF GENE & CELL THERAPY
Based in WAUKESHA, WI, THE AMERICAN SOCIETY OF GENE & CELL THERAPY operates as a Public Charity. The organization reported $16.9M in revenue, $14.6M in expenses, $27.0M in total assets for fiscal year 2024. Imperigo tracks 8 reported grant relationships connected to this organization totaling approximately $1.0M.
EIN: 911766321
WAUKESHA, WI
Birth Defects & Genetic Diseases Research
NTEE: H20
Latest filing: 2024
Total Revenue$16.9M
Total Expenses$14.6M
Total Assets$27.0M
Grant Records8
Funding Total$1.0M
Filing Years2019–2024
Where $100 goes at The American Society of Gene & Cell Therapy
How The American Society of Gene & Cell Therapy divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$80
Programs
the work itself
$16
Management
running the organization
$4
Fundraising
raising the next dollar
Inside the $80 for programs
$43
Annual meeting
$24
Other programs include
$7
Molecular therapy journals
Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
RESEARCH
$100,000
THERAPEUTICS DISCOVERY RESEARCH
$100,000
RESEARCH
$100,000
RESEARCH
$75,000
THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1.
$33,334
Showing up to 5 of 8 total records — full history available with membership.
Officers & Directors
DIRECTOR
Aravind Asokan Phd
PART YEAR DIRECTOR
Claire Booth Mbbs Phd
DIRECTOR
Daniel E Bauer Md Phd
EXECUTIVE DIRECTOR
David Barrett
TREASURER
Federico Mingozzi Phd
PAST PRESIDENT
Hans-Peter Kiem Md Phd
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $16.9M | $14.6M | $27.0M |
| 2023 | $16.4M | $13.8M | $23.8M |
| 2022 | $12.5M | $11.0M | $20.5M |
| 2020 | $6.5M | $4.5M | $11.5M |
| 2019 | $6.5M | $4.7M | $9.7M |
Between 2019 and 2024, reported annual revenue grew from $6.5M to $16.9M (+160%), with total assets most recently reported at $27.0M.
Interactive year-over-year charts and full filing details available with membership.